{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:03:49Z","timestamp":1790424229046,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS070715"],"award-info":[{"award-number":["R01-NS070715"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.neuropharm.2020.107935","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T01:50:45Z","timestamp":1578361845000},"page":"107935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy"],"prefix":"10.1016","volume":"166","author":[{"given":"Dana E.","family":"Selley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6768-7025","authenticated-orcid":false,"given":"Matthew F.","family":"Lazenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Sim-Selley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Secor McVoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena H.","family":"Chartoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Carlezon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.107935_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/1098-2396(20010315)39:4<343::AID-SYN1018>3.0.CO;2-Q","article-title":"Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593","volume":"39","author":"Acri","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2020.107935_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuron.2010.03.002","article-title":"Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain","volume":"66","author":"Baliki","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107935_bib3","doi-asserted-by":"crossref","first-page":"16383","DOI":"10.1523\/JNEUROSCI.1731-13.2013","article-title":"Parceling human accumbens into putative core and shell dissociates encoding of values for reward and pain","volume":"33","author":"Baliki","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107935_bib4","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1073\/pnas.0502418102","article-title":"Dopamine responsiveness is regulated by targeted sorting of D2 receptors","volume":"102","author":"Bartlett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107935_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.107935_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ejpain.2007.12.007","article-title":"Signal valence in the nucleus accumbens to pain onset and offset","volume":"12","author":"Becerra","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.pain.2014.02.019","article-title":"Role of nucleus accumbens in neuropathic pain: linked multi-scale evidence in the rat transitioning to neuropathic pain","volume":"155","author":"Chang","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2007.03.021","article-title":"Coordinated accumbal dopamine release and neural activity drive goal-directed behavior","volume":"54","author":"Cheer","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107935_bib9","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neuropharm.2020.107935_bib10","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00213-017-4584-y","article-title":"Social defeat disrupts reward learning and potentiates striatal nociceptin\/orphanin FQ mRNA in rats","volume":"234","author":"Der-Avakian","year":"2017","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2020.107935_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/ALN.0b013e3182330448","article-title":"Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids","volume":"115","author":"Ewan","year":"2011","journal-title":"Anesthesiology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2020.107935_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2008.06.076","article-title":"Looking for the role of cannabinoid receptor heteromers in striatal function","volume":"56","author":"Ferre","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107935_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107935_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1054\/jpai.2001.9804","article-title":"Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw","volume":"2","author":"Fu","year":"2001","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09358","article-title":"Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium","volume":"4","author":"Gantz","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2020.107935_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)00247-N","article-title":"The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum","volume":"681","author":"Gilbert","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107935_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpain.2013.10.001","article-title":"Suppression of voluntary wheel running in rats is dependent on the site of inflammation: evidence for voluntary running as a measure of hind paw-evoked pain","volume":"15","author":"Grace","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41467-017-02776-7","article-title":"Impaired beta-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor","volume":"9","author":"Gray","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.107935_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2016.05.010","article-title":"G protein-coupled receptor kinases as regulators of dopamine receptor functions","volume":"111","author":"Gurevich","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2020.107935_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0306-4522(92)90155-U","article-title":"Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling","volume":"46","author":"Herve","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107935_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2015.04.018","article-title":"Basal ganglia circuit loops, dopamine and motivation: a review and enquiry","volume":"290","author":"Ikemoto","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107935_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<275::AID-SYN5>3.0.CO;2-8","article-title":"Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors","volume":"30","author":"Izenwasser","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2020.107935_bib24","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1073\/pnas.95.13.7731","article-title":"Prominence of the dopamine D2 short isoform in dopaminergic pathways","volume":"95","author":"Khan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107935_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/jpet.117.240796","article-title":"Relief of pain-depressed behavior in rats by activation of D1-like dopamine receptors","volume":"362","author":"Lazenka","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2020.107935_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/can.2017.0022","article-title":"Delta(9)-Tetrahydrocannabinol experience influences DeltaFosB and downstream gene expression in prefrontal cortex","volume":"2","author":"Lazenka","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neuropharm.2020.107935_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/pha0000067","article-title":"Opposing effects of dopamine D1- and D2-like agonists on intracranial self-stimulation in male rats","volume":"24","author":"Lazenka","year":"2016","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.107935_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.115.224428","article-title":"Role of dopamine type 1 receptors and dopamine- and cAMP-regulated phosphoprotein Mr 32 kDa in delta9-tetrahydrocannabinol-mediated induction of DeltaFosB in the mouse forebrain","volume":"354","author":"Lazenka","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2020.107935_bib29","first-page":"753905","article-title":"Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats","author":"Legakis","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2020.107935_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/FBP.0000000000000378","article-title":"Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity","volume":"29","author":"Legakis","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107935_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/FBP.0000000000000207","article-title":"Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and \u03b49-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats","volume":"27","author":"Leitl","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107935_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/npp.2013.236","article-title":"Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous kappa-opioids","volume":"39","author":"Leitl","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107935_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1744-8069-10-62","article-title":"Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats","volume":"10","author":"Leitl","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib34","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0730708100","article-title":"Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites","volume":"100","author":"Lindgren","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107935_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1471-4159.2004.02998.x","article-title":"Dopamine D1 receptor interaction with arrestin3 in neostriatal neurons","volume":"93","author":"Macey","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.107935_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(02)02489-7","article-title":"Additional evidence for the involvement of the basal ganglia in formalin-induced nociception: the role of the nucleus accumbens","volume":"942","author":"Magnusson","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107935_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejphar.2018.07.038","article-title":"Dopaminergic and serotonergic mechanisms in the modulation of pain: in vivo studies in human brain","volume":"834","author":"Martikainen","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107935_bib38","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1523\/JNEUROSCI.4605-14.2015","article-title":"Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum","volume":"35","author":"Martikainen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107935_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pain.0000000000000018","article-title":"Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats","volume":"156","author":"Miller","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2016.05.017","article-title":"Modulation of pain, nociception, and analgesia by the brain reward center","volume":"338","author":"Mitsi","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107935_bib41","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.neuropharm.2020.107935_bib42","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.1073\/pnas.1214605109","article-title":"Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry","volume":"109","author":"Navratilova","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107935_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/pr.118.017210","article-title":"Core outcome measures in preclinical assessment of candidate analgesics","volume":"71","author":"Negus","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.107935_bib44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuroscience.2013.06.035","article-title":"Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: comparing D2L and D2S","volume":"248","author":"Neve","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107935_bib45","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1097\/j.pain.0000000000000695","article-title":"Hedonic and motivational responses to food reward are unchanged in rats with neuropathic pain","volume":"157","author":"Okun","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cne.20881","article-title":"Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens","volume":"495","author":"Pickel","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107935_bib47","first-page":"1","article-title":"Involvement of D2 receptor in the NAc in chronic unpredictable stress-induced depression-like behaviors","author":"Qiao","year":"2019","journal-title":"Stress"},{"key":"10.1016\/j.neuropharm.2020.107935_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nn.4199","article-title":"The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain","volume":"19","author":"Ren","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107935_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpain.2012.11.006","article-title":"Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats","volume":"14","author":"Rosenberg","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuropharm.2015.06.003","article-title":"Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain","volume":"97","author":"Sagheddu","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107935_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/j.pain.0000000000001066","article-title":"Nucleus accumbens mediates the pronociceptive effect of sleep deprivation: the role of adenosine A2A and dopamine D2 receptors","volume":"159","author":"Sardi","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.1253994","article-title":"Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens","volume":"345","author":"Schwartz","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107935_bib53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.57.9.1583","article-title":"Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain","volume":"57","author":"Semenchuk","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2020.107935_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/npp.2009.93","article-title":"Cortico-Basal Ganglia reward network: microcircuitry","volume":"35","author":"Sesack","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.107935_bib55","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.neuropharm.2011.08.046","article-title":"Effect of DeltaFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens","volume":"61","author":"Sim-Selley","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.107935_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.107935_bib57","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/j.pain.0000000000000494","article-title":"Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction","volume":"157","author":"Taylor","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.107935_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011038","article-title":"Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine","volume":"5","author":"Thompson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2020.107935_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35041572","article-title":"Distinct functions of the two isoforms of dopamine D2 receptors","volume":"408","author":"Usiello","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.107935_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-981-13-1756-9_17","article-title":"Brain reward circuit and pain","volume":"1099","author":"Watanabe","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2020.107935_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.114.218677","article-title":"Delta9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice","volume":"352","author":"Wiebelhaus","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2020.107935_bib62","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00213-014-3796-7","article-title":"Social defeat stress-induced sensitization and escalated cocaine self-administration: the role of ERK signaling in the rat ventral tegmental area","volume":"232","author":"Yap","year":"2015","journal-title":"Psychopharmacology (Berlin)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:59:53Z","timestamp":1758437993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820300010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":62,"alternative-id":["S0028390820300010"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107935","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/722801","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107935"}}